The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
Ann Oncol. 2022
M. Di Maio, E. Basch, F. Denis et al, on behalf of the ESMO Guidelines Committee
- This ESMO Guideline provides key recommendations on the role of PROMs during the care of patients with cancer.
- It covers the use of PROMs in patients with cancer from the start of active treatment during follow-up and at the end of life.
- Recommendations are based on available scientific evidence and the authors’ collective expert consensus.
- Authorship includes a multidisciplinary group of experts from Europe, North America, Asia & Australia.